Skip to main content

Table 1 Subject disposition

From: Extended dosing of darbepoetin alfa in peritoneal dialysis patients

 

n (%)

Eligible subjects (full analysis set)

741

Subjects who completed study

640 (86.4)

Subjects who discontinued study

101 (13.6)

   Kidney transplant

39 (38.6)a

   Death

36 (35.6)a

   No longer treated at clinic

15 (14.9)a

   Consent withdrawn

1 (1.0)a

   Other

10 (9.9)a

  1. aPercentage of all subjects who discontinued the study